Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 59746-591 by Jubilant Cadista Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

cartonlabel - carton

cartonlabel - carton

figure4 - fig04

figure4 - fig04

This is a graph that shows the distribution of patients who took a placebo (97 patients) and levetiracetam (101 patients) across different percentage values, ranging from 0% to 45%. The percentage values represent the proportion of patients who experienced a certain outcome, but the nature of the outcome and what the percentages represent is not available.*

figure5 - fig05

figure5 - fig05

This appears to be a chart or graph showing the percentage of patients who took either a placebo or a medication called Levetiracetam (abbreviated as IY) and the corresponding percentage of effectiveness. This information is not enough to determine what condition the medication was being used to treat, or what the percentages represent specifically.*

figure6 - fig06

figure6 - fig06

This is a table showing the percentage of patients in two groups, the placebo group and the Levetiracetam group. The table has values ranging from 0% to 100%, with both groups having different percentages at various intervals. The number of patients for each group is also mentioned, with 84 patients in the placebo group and 79 patients in the Levetiracetam group. No further information is provided.*

figure1 - figure01

figure1 - figure01

figure2 - figure02

figure2 - figure02

This appears to be a chart showing the percentages of patients in a medical study who were prescribed varying dosages of Levetiracetam (a medication used to treat seizures) as well as a placebo group. The percentages range from 0% to 45%, with the highest percentage being associated with the group taking 1000mg/day of the medication. There is also a column that shows the number of patients associated with each group. Overall, this appears to be a data table from a medical study evaluating the efficacy of Levetiracetam.*

figure3 - figure03

figure3 - figure03

structural fig - structure

structural fig - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.